Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Energy and Commerce/Oversight Subcommittee

This article was originally published in The Gray Sheet

Executive Summary

Staffer Claudia Beville is leaving the Hill in early July and will be replaced by Mary Murray, a staffer in FDA's Office of Investigations. Beville reportedly has no immediate plans to take another job. Beville's tenure at the subcommittee included investigations into FDA's response to Bjork-Shiley heart valve failures in 1990 and into the agency's device good manufacturing practices and pre-market review programs in 1992. Beville authored a June 1993 subcommittee report on FDA's Center for Devices and Radiological Health entitled "Less Than the Sum of Its Parts" ("The Gray Sheet" June 7, 1993, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel